Alexander I. Mosa
Co-founder
Biossil
AI-native biopharma resuscitating failed drug candidates for late-stage programs
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Biossil is a Toronto-based AI-native biopharmaceutical company that uses large language models to identify previously failed drug candidates and advance them in biologically defined patient populations. It is advancing late-stage programs across indications including sickle cell disease, idiopathic pulmonary fibrosis, glioblastoma, breast cancer, and Alzheimer disease. The company is led by Alexander I. Mosa and Anthony Mouchantaf and has been backed by OpenAI and Founders Fund, among others.
- Website
- biossil.ai
- Location
- Toronto, Canada
- Added via
- web
- Ownership
- unclaimed
Where to go
Social profiles
Links
Founders
Anthony Mouchantaf
Co-founder